Michael J. Hall, MD, MS

Request an Appointment Online - Click Here New patients can request an appointment online or call

Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111-2497

Video: Michael Hall, MD, MS

Michael Hall, MD, MS

Hepatobiliary and Pancreatic Cancer Treatment at Fox Chase Cancer Center

GI Service Line

Learn about hepatobiliary and pancreatic cancer care at Fox Chase Cancer Center. From diagnosis to treatment to concerns about your family, our team has experience than can help. (9 min.)

Gastrointestinal Cancer Risk Assessment

Gastrointestinal Cancer Risk Assessment

Dr. Michael Hall talks about the High Risk Colon Cancer Clinic, part of the Gastrointestinal Cancer Risk Assessment program at Fox Chase Cancer Center. (1:10.)

Patient Stories from Fox Chase Patients Dr. Hall's
Patient Stories

Next Generation Sequencing-Based Tumor Genomic Profiling Aids in Detecting Hereditary Variants in Cancer Risk Genes
(May 20, 2015)

Dr. Hall on Multigene Target Panels for Genetic Weaknesses

OncLive, July 2, 2015
Michael Hall, MD, MS, Director of Gastrointestinal Risk Assessment, and Assistant Professor at Fox Chase Cancer Center, was featured in an OncLive video on multigene target panels to determine genetic weaknesses. "Multigene panels have been developed for practitioners to evaluate tumors for genetic and genomic weaknesses," Hall explains. "However, the fact that detected mutations within tumors are reflective of potential germline variations is understudied. This should be a significant area of research, because patients may be at risk for other cancers or may be unaware of risks associated with their family history."

Dr. Michael Hall

Clinical Genetics

Director, Gastrointestinal Risk Assessment 
Assistant Professor 

Meet other members of the
gastrointestinal cancer treatment team
Learn more about Risk Assessment.

Clinical Expertise:

Risk assessment for hereditary cancer, focus on tumors of the gastrointestinal tract; treatment of Gastrointestinal Cancers ( Pancreatic Cancer, Colorectal Cancer, Carcinoid Tumors, neuroendocrine, Stomach Cancer, Liver Cancer, small bowel, appendix, and anal)


American Board of Internal Medicine;
Medical Oncology;

Medical Education

MD, Columbia Unversity, New York, NY, 1999;
MS, University of Chicago, 2005


Internal Medicine, Harvard University, Brigham and Women's Hospital, Boston, MA


Fellow, Cancer Prevention and Control, Mailman School of Public Health, Columbia University, New York, NY, 2006;
Fellow, Hematology/Oncology, University of Chicago, 2005.

Honors and Awards

American Cancer Society Mentored Research Scholar Grant 2007;
Young Investigator Award, American Society of Clinical Oncology, 2006;
Merit Award, American Society of Clinical Oncology, 2003-2005;
Honrary Alpha Omega Alpha, University of Chicago, 2004;
Excellence in Teaching Award, Harvard University Medical School, 2001;
Alpha Omega Alpha, Columbia College of Physicians and Surgeons, 1999.

Research Interests

The role of BRCA1/2 in hereditary pancreatic cancer;
Racial/ethnic disparities in genetic testing for cancer disposition;
Decision analysis and costs in genetic testing for cancer predisposition and other cancer-related genetic tests